Evidence map›Paper›PMID 33761909›Full record

Trial reportBMC pulmonary medicine2021

Deep learning diagnostic and risk-stratification pattern detection for COVID-19 in digital lung auscultations: clinical protocol for a case-control and prospective cohort study.

Alban Glangetas, Mary-Anne Hartley, Aymeric Cantais, Delphine S Courvoisier, David Rivollet, Deeksha M Shama, Alexandre Perez, Hervé Spechbach, Véronique Trombert, Stéphane Bourquin and 4 more

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMC pulmonary medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Alban Glangetas *Division of Paediatric Emergency Medicine, Department of Women, Child and Adolescent, Geneva University Hospitals, 47 Avenue de la Roseraie, 1205, Geneva, Switzerland.
Mary-Anne Hartley *Intelligent Global Health, Machine Learning and Optimization (MLO) Laboratory, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Aymeric CantaisDivision of Paediatric Emergency Medicine, Department of Women, Child and Adolescent, Geneva University Hospitals, 47 Avenue de la Roseraie, 1205, Geneva, Switzerland.
Delphine S CourvoisierQuality of Care Unit, Geneva University Hospitals, Geneva, Switzerland.
David RivolletEssential Tech Centre, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Deeksha M ShamaIntelligent Global Health, Machine Learning and Optimization (MLO) Laboratory, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Alexandre PerezGeneva University Hospitals, Geneva, Switzerland.
Hervé SpechbachDivision of Primary Care Medicine, Department of Community Medicine, Geneva University Hospitals, Geneva, Switzerland.
Véronique TrombertDepartment of Internal Medicine and Rehabilitation, Geneva University Hospitals, Geneva, Switzerland.
Stéphane BourquinDepartment of Micro-Engineering, Geneva School of Engineering, Architecture and Landscape (HEPIA), Geneva, Switzerland.
Martin JaggiIntelligent Global Health, Machine Learning and Optimization (MLO) Laboratory, Swiss Federal Institute of Technology (EPFL), Lausanne, Switzerland.
Constance Barazzone-ArgiroffoPaediatric Pulmonology Unit, Department of Women, Child and Adolescent, University Hospitals of Geneva, Geneva, Switzerland.
Alain GervaixDivision of Paediatric Emergency Medicine, Department of Women, Child and Adolescent, Geneva University Hospitals, 47 Avenue de la Roseraie, 1205, Geneva, Switzerland.
Johan N SiebertDivision of Paediatric Emergency Medicine, Department of Women, Child and Adolescent, Geneva University Hospitals, 47 Avenue de la Roseraie, 1205, Geneva, Switzerland. Johan.Siebert@hcuge.ch.ORCID http://orcid.org/0000-0002-2871-3382
University Hospital of Geneva · CHÉcole Polytechnique Fédérale de Lausanne · CHHES-SO Genève · CH

Funding

Hôpitaux Universitaires de Genève 135-SIA-SARS-CoV-2 COVID
6 · The paper itself

Abstract

backgroundLung auscultation is fundamental to the clinical diagnosis of respiratory disease. However, auscultation is a subjective practice and interpretations vary widely between users. The digitization of auscultation acquisition and interpretation is a particularly promising strategy for diagnosing and monitoring infectious diseases such as Coronavirus-19 disease (COVID-19) where automated analyses could help decentralise care and better inform decision-making in telemedicine. This protocol describes the standardised collection of lung auscultations in COVID-19 triage sites and a deep learning approach to diagnostic and prognostic modelling for future incorporation into an intelligent autonomous stethoscope benchmarked against human expert interpretation.

methodsA total of 1000 consecutive, patients aged ≥ 16 years and meeting COVID-19 testing criteria will be recruited at screening sites and amongst inpatients of the internal medicine department at the Geneva University Hospitals, starting from October 2020. COVID-19 is diagnosed by RT-PCR on a nasopharyngeal swab and COVID-positive patients are followed up until outcome (i.e., discharge, hospitalisation, intubation and/or death). At inclusion, demographic and clinical data are collected, such as age, sex, medical history, and signs and symptoms of the current episode. Additionally, lung auscultation will be recorded with a digital stethoscope at 6 thoracic sites in each patient. A deep learning algorithm (DeepBreath) using a Convolutional Neural Network (CNN) and Support Vector Machine classifier will be trained on these audio recordings to derive an automated prediction of diagnostic (COVID positive vs negative) and risk stratification categories (mild to severe). The performance of this model will be compared to a human prediction baseline on a random subset of lung sounds, where blinded physicians are asked to classify the audios into the same categories. DISCUSSION: This approach has broad potential to standardise the evaluation of lung auscultation in COVID-19 at various levels of healthcare, especially in the context of decentralised triage and monitoring.

trial registrationPB_2016-00500, SwissEthics. Registered on 6 April 2020.

Indexed as

Deep LearningAdolescentAdultAgedAged, 80 and overAlgorithmsAuscultationCase-Control StudiesClinical Decision RulesClinical ProtocolsCOVID-19COVID-19 TestingFemaleHumansMaleMiddle AgedArtificial intelligenceAuscultationCOVID-19Deep learningPneumoniaRespiratory soundsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Identifiers

PMID33761909
PMCPMC7988633
OpenAlexW3136868560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.